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Abstract
Background: Vitamin A is necessary for kidney development and has also been linked to regulation of solute and water
homeostasis and to protection against kidney stone disease, infection, inflammation, and scarring. Most functions of vitamin
A are mediated by its main active form, all-trans retinoic acid (tRA), which binds retinoic acid receptors (RARs) to modulate
gene expression. We and others have recently reported that renal tRA/RAR activity is confined to the ureteric bud (UB) and
collecting duct (CD) cell lineage, suggesting that endogenous tRA/RARs primarily act through regulating gene expression in
these cells in embryonic and adult kidney, respectively.
Methodology/Principal Findings: To explore target genes of endogenous tRA/RARs, we employed the mIMCD-3 mouse
inner medullary CD cell line, which is a model of CD principal cells and exhibits constitutive tRA/RAR activity as CD principal
cells do in vivo. Combining antagonism of RARs, inhibition of tRA synthesis, exposure to exogenous tRA, and gene
expression profiling techniques, we have identified 125 genes as candidate targets and validated 20 genes that were highly
regulated (Dhrs3, Sprr1a, and Ppbp were the top three). Endogenous tRA/RARs were more important in maintaining, rather
than suppressing, constitutive gene expression. Although many identified genes were expressed in UBs and/or CDs, their
exact functions in this cell lineage are still poorly defined. Nevertheless, gene ontology analysis suggests that these genes
are involved in kidney development, renal functioning, and regulation of tRA signaling.
Conclusions/Significance: A rigorous approach to defining target genes for endogenous tRA/RARs has been established. At
the pan-genomic level, genes regulated by endogenous tRA/RARs in a CD cell line have been catalogued for the first time.
Such a catalogue will guide further studies on molecular mediators of endogenous tRA/RARs during kidney development
and in relation to renal defects associated with vitamin A deficiency.
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Introduction
All-trans retinoic acid (tRA) is the primary bioactive form of
endogenous retinoids derived from dietary vitamin A and plays
important roles in regulating a myriad of physiological events
[1]. One of the major mechanisms through which tRA exerts its
biological activity is by binding and activating its cognate
nuclear receptors, the retinoic acid receptors (RARs) a, b, c,
and retinoid X receptors (RXRs) a, b, c, which heterodimerize
to act as transcription factors, thereby modulating gene
transcription [2]. Direct target genes of tRA are often
characterized by the presence of one or more retinoic acid
response elements (RAREs) in the gene regulatory region, which
serve as anchorage points for the RXR-RAR heterodimers
[3,4]. A RARE typically consists of two direct repeats (DR) of
the hexameric motif PuG(G/T)TCA, separated by 1, 2, or 5
nucleotides, referred to as DR1, DR2, and DR5, respectively
[2]. While DR5 RAREs represents the most potent classical
RARE for transcriptional activity regulation, other forms of
non-classical RAREs, e.g., hexameric motifs spaced by more
than 5 nucleotides, and imperfect hexameric motifs have been
described [3]. Other than the canonical tRA/RAR/RARE
signaling, various non-canonical signaling events of retinoids,
such as RAR-independent signaling and the involvement of
ligands other than tRA, have been described [5]. In addition to
the multiplicity of retinoid signaling, the presence of endogenous
retinoids is also intricately controlled by multiple synthesizing
and metabolizing enzymes, including medium-chain and short-
chain dehydrogenases, retinaldehyde dehydrogenases (Raldhs),
and the cytochrome P450 family 26 [6]. It is thus not surprising
that retinoid signaling is highly complex, reflected in its diverse
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and seemingly paradoxical effects, depending on different cell
types and different settings.
It is well established that the endogenous tRA and RARs are
indispensable for embryonic kidney development [7]. Even mild
gestational vitamin A deficiency leads to a deficit in nephron
number, which may predispose the kidney to abnormal develop-
ment or function when associated with other morbidities [8].
Using RARE-hsp68-lacZ mice as a reporter model, we recently
described the presence of a RARE reporter signal indicative of
RAR-dependent tRA activity in the collecting ducts (CDs) of
young and adult mouse kidneys [9]. Our observation of this
RARE reporter signal in the CDs is similar to the finding of
Rosselot et al., who described the presence of a RARE reporter
signal in the ureteric buds (UBs) of embryonic kidney, which are
the embryonic precursors of CDs [10]. Thus, RARE activity in
healthy kidneys appears to be confined to the UB/CD cell lineage.
The observation of RARE reporter activity in the UB/CD cell
lineage has important implications. Initially Batourina et al
proposed that kidney stromal mesenchyme is the primary site of
action for tRA/RAR signaling in embryonic kidneys; the signal
being delivered to the UB to regulate Ret expression, which
stimulates ureteric bud branching and initiates kidney develop-
ment [11]. The same group recently revised this model and
proposed that tRA/RAR signaling was actually initiated in the UB
cells rather than in the stromal mesenchyme [10]. The revised
model is in good concordance with the presence of a RARE
reporter signal in UB cells. Nevertheless, tRA/RAR target genes
in UB cells remain largely unknown, as are the tRA/RAR target
genes in UB-derived CDs. Because RARs are nuclear transcrip-
tion factors known to regulate gene transcription, and in view of
the continuity of tRA/RAR signaling in the UB/CD cell lineage
in embryonic and postnatal kidneys [9,10], it is relevant to explore
what genes are under the control of the endogenous tRA/RARs in
CD cells.
To explore target genes of endogenous tRA/RARs in the UB/
CD cell lineage, we performed microarray experiments using
mIMCD-3 as an in vitro cell model. mIMCD-3 is a well-
characterized inner medullary CD cell line [12], which has been
widely used in a variety of studies to explore the functions and
activities of UB/CD cells: ion channel signaling [13,14], signaling
during osmotic and hypertonic stress [15], urea signaling [16], and
branching morphogenesis [17]. We used two different chemicals to
disrupt endogenous tRA/RAR signaling at different stages: (i)
AGN193109 [18], a pan-antagonist of RARs, which competes
with endogenous tRA for RAR binding, and (ii) 4-(diethylamino)-
benzaldehyde (DEAB) [19], an inhibitor of Raldhs, which inhibits
endogenous tRA biosynthesis. To confirm the specificity of these
chemical reagents, exogenous tRA was added simultaneously to
determine if their effects could be abolished (Figure 1).
Results
The mIMCD-3 Cell Line Simulates CD Cells in vivo,
Expressing Epithelial and CD Principal Cell Markers and
Demonstrating Constitutive tRA/RAR Activity
mIMCD-3 cells expressed E-cadherin, a marker of epithelial
cells (Figure 2Ai), and aquaporin 2, a marker of CD principal cells
(Figure 2Aii), confirming its epithelial and CD-like phenotype.
After confirming the identity of mIMCD-3 cells, we examined the
presence of RARE-reporter activity by transfecting the cells with
pGL3-RARE-luciferase reporter plasmid. By treating mIMCD-3
cells with AGN193109, basal RARE-luciferase activity was
reduced to about 50% of that of the vehicle control group; when
exogenous tRA was added with AGN193109, the reduction of
RARE-luciferase activity was abolished in a dose-dependent
manner (Figure 2Bi). Similarly, when mIMCD-3 cells were treated
with DEAB, a reduction of basal RARE-luciferase activity was
observed, which was reversed when exogenous tRA was added
(Figure 2Bii). Note that the RARE-luciferase activity was reversed
to a level similar to the vehicle control group at 0.1 nM tRA; the
RARE-luciferase activity was saturated by 1 nM tRA, which was
about 1.75-fold of that of the vehicle control group and about 3.5-
fold of that of the DEAB-treated group (Figure 2Bii). Under
culture conditions, when RARE-luciferase transfected mIMCD-3
cells were treated with exogenous tRA alone, the induction of
RARE-luciferase activity was weak and did not reach statistical
significance (Figure 2Biii), suggesting that the constitutive RARE
activity induced by endogenous tRA/RARs was close to saturation
for activating the reporter construct.
Candidate Target Genes of Endogenous tRA/RARs
Two sets of independent biological experiments (N= 3 each)
were performed: (i) cells treated with AGN193109, with and
without tRA, to identify candidate genes regulated by RARs, and
(ii) cells treated with DEAB, with and without tRA, to identify
candidate genes regulated by endogenous tRA. Samples taken
from these studies were subjected to microarray analysis, in which
candidate target genes of endogenous tRA/RARs were defined as
those genes regulated in the same direction by both AGN193109
and DEAB, with the regulation partially or completely abolished
by exogenous tRA at concentrations used in the earlier studies
shown in Figure 2. Partial abolishment included a statistical
difference between the ‘‘inhibitor-only’’ and ‘‘inhibitor with tRA’’
groups, or no statistical difference between the ‘‘inhibitor with
tRA’’ and ‘‘vehicle control’’ groups.
Prior to microarray experiments, a small group of pilot reverse-
transcription-quantitative polymerase chain reaction (RT-qPCR)
studies was performed to examine the expression of a few genes of
interest to verify the effectiveness of our strategy, as well as to guide
the process of shortlisting target genes in the ensuing microarray
studies. For this purpose, we selected Bmp7, Foxa1, Pax2, and
Wnt7b, which have been implicated in kidney development, water
transport, and defense/protection mechanism against injury
[15,20,21,22,23]. These genes have been reported in other
systems to be regulated by tRA with or without known functional
RARE [24,25,26,27]. As shown in Figure 3, Bmp7 and Foxa1
mRNAs were suppressed by both AGN193109 and DEAB; the
suppression was at least partially abolished when exogenous tRA
was added simultaneously. On the other hand, Wnt7b and Pax2
mRNAs were not significantly regulated by either AGN193109 or
by DEAB (data not shown).
Given that the magnitude of regulation for Foxa1 was lower
than that of Bmp7, and the effects of exogenous tRA did not reach
significance, Foxa1 was used as a cut-off threshold for shortlisting
candidate target genes (details described in the Materials and
Methods section): 403 and 439 unique genes were generated from
AGN193109 experiments and DEAB experiments, respectively.
As shown in Figure 4A, there were 133 overlapping genes; of
these, 125 were similarly regulated by AGN193109 and by DEAB,
and the regulation was at least partially abolished in the
simultaneous presence of exogenous tRA. These 125 genes were
categorized as the group 1 genes that represent specific target
genes of endogenous tRA/RARs. In addition to the group 1 genes,
there were 213 genes designated as group 2 genes that were
regulated only by AGN193109, but not DEAB. These were
candidate genes regulated by RARs, but not endogenous tRA.
There were 266 additional genes designated as group 3 genes that
were regulated only by DEAB, but not AGN193109. They were
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considered as candidate genes regulated by endogenous tRA, but
independent of RARs (Figure 4A). When the genes were ranked
by fold-changes, 16 out of the top 20 and 9 out of the top 10 most
highly regulated genes overlapped (Figure 4B and 4C), suggesting
that the most regulated genes were dependent on both tRA and
RARs. Thus, further analysis was focused on the tRA/RAR-
dependent genes (group 1).
The number and fold-changes of all group 1 genes are
summarized in Figure 5. The total number of genes suppressed
by both AGN193109 and DEAB were approximately 3-fold more
than those induced by both AGN193109 and DEAB. Of note,
there were 19 and 12 genes suppressed by AGN193109 and
DEAB by 2-fold or more, respectively, but none was induced by 2-
fold or more, indicating that tRA/RARs play a more important
role in maintaining, rather than suppressing, gene expression. The
top 20 most down- and up-regulated genes within group 1 are
listed in Table 1 and Table 2, respectively. The complete lists of
genes regulated by AGN193109 and by DEAB, genes regulated
only by AGN193109 and genes regulated only by DEAB, are
compiled in Tables S1, S2, S3. Original raw data of microarray
experiments have been deposited in NCBI’s Gene Expression
Omnibus (GEO) and are accessible through GEO Series accession
number GSE33955 (http://www.ncbi.nlm.nih.gov/geo/query/
acc. cgi?acc =GSE33955).
Validation of Microarray Results
The top 20 most highly regulated genes shortlisted from the
microarray experiments were all down-regulated by AGN193109
and by DEAB. Regulation of these genes was validated by RT-
qPCR. As shown in Table 3, among the 20 genes examined, 19
were significantly down-regulated by AGN193109; suppression of
all these genes, except Muc20, was at least partially abolished in
the presence of exogenous tRA. The same 19 genes were also
significantly down-regulated by DEAB and suppression was
abolished in the presence of exogenous tRA. Thus, while Csn3,
which was not amplified, and Muc20 need further investigation,
the remaining 18 genes, along with Bmp7 and Foxa1 examined in
the pilot study, were confirmed as specific target genes of
endogenous tRA/RARs.
Gene Ontology Analysis
The 125 candidate target genes of endogenous tRA/RARs were
subjected to GeneGO MetacoreTM analysis to determine if they
are enriched for a particular set of biological processes and
diseases. As shown in Table S4, the top 50 biological processes in
which the candidate target genes are involved can be broadly
categorized into six main groups: 42% of the top 50 biological
processes are under the umbrella of developmental processes or
morphogenesis, 20% are in cell fate determination, 16% are in
response towards stimuli, 14% are in regulation of signal
transduction, 4% are in cell communication, and the remaining
4% are in other processes (Figure 6A). These genes were also
reported to be dysregulated in some diseases, including fibrosis,
wounds healing, immune system diseases, and renal inflammation
(Figure 6A).
Expression of the validated genes in native tissues was
determined using two GEO series deemed relevant to mIMCD-
3 cells: (i) E11.5 mouse UBs and E15.5 mouse medullary CD cells
(GEO accession: GSE6290), contributed by GenitoUrinary
Development Molecular Anatomy Project (GUDMAP) (http://
www.gudmap.org/), and (ii) inner medullary CD cells derived
from 6- and 10-week-old rat kidney (GEO accession: GSE7891),
contributed by Uawithya et al [28]. There were three biological
replicates in each of the database; a gene was considered as
positively expressed if at least two out of three replicates had
positive hybridization signal. As shown in Figure 6B, expression of
all the 20 genes, except for 9930023K05Rik, 2310007B03Rik, and
Itga2, was found in at least one native sample of UB/CD cells. In
addition, by referring to a recently published database of DR5
RARE in mouse whole genome [4], it was found that 13 out of the
20 validated genes contain at least one DR5 RARE. Of these 13
genes, 11 of them have at least one DR5 RARE within 10 kb from
the transcription start sites and from gene ends (Figure 6B), which
are regions deemed highly relevant for transcriptional activity
modulation [4].
Gene ontologies for each validated gene were also examined
and classified since these genes showed the greatest amount of
change (Figure 6B). These genes were reported to be involved in
regulating the conversion of tRal into tRol (Dhrs3), regulating UB
branching and kidney development (Ppbp and Bmp7), maintain-
ing CD cell polarity and integrity by regulating cell-cell and cell-
substrate interactions (Tns1 and Itga2), regulating cellular
responses to stress and modulating tissue repair (Sprr1a, Cpm,
Lcn2, and Bmp7), regulating water and solute transport mecha-
nisms, and kidney stone formation (Npr3, Foxa1, Clca4, Slc37a1,
and Galns). The known functions of these identified tRA/RAR
Figure 1. Strategy employed to examine endogenous tRA/RAR signaling and its target genes. In cells, all-trans retinol (tRol), i.e., vitamin
A, is oxidized reversibly to all-trans retinaldehyde (tRal), catalyzed by the enzymes retinol dehydrogenases (Rdhs) or alcohol dehydrogenases (Adhs).
tRal is then oxidized irreversibly to all-trans retinoic acid (tRA), catalyzed by retinaldehyde dehydrogenases (Raldhs). tRA translocates into cell nucleus
to bind and activate retinoic acid receptors (RARs), modulating gene transcription. AGN193109 (purple) and 4-(diethylamino)benzaldehyde (DEAB,
orange) were used to compete with tRA for RAR binding and to inhibit Raldhs in the conversion of tRal into tRA, respectively. Specificity of inhibition
was confirmed by adding exogenous tRA (red) simultaneously to examine if the effects of AGN193109 and DEAB could be at least partially abolished.
doi:10.1371/journal.pone.0045725.g001
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target genes might help in understanding how tRA/RARs
function at the molecular level in the UB/CD cell lineage and
guide future studies. In addition, further studies of the function of
some genes with unknown functions (9930023K05Rik, Klhdc7a,
Sorcs2, and 2310007B03Rik) or functions not yet associated with
UB/CD cells and the kidney (Ebf1, Upk3b, and Hrsp12) might
not only help to better understand the functions of these genes, but
also might help to discover novel functions of the UB/CD cell
lineage. The complete list of gene ontologies of the validated genes
was listed in Table S5.
Discussion
In this study, we have detected the presence of constitutive RAR
activation following continuous stimulation by endogenous tRA in
mIMCD-3 cells (Figure 2). Specifically, AGN193109 and DEAB
treatment reduced RARE-luciferase activity, indicating the
presence of basal tRA/RAR signaling in mIMCD-3 cells; this
effect was abolished by exogenous tRA, in a dose-dependent
manner, confirming the specificity of AGN193109 and DEAB.
Interestingly, exogenous tRA treatment alone resulted in only
weak induction of RARE-luciferase activity, although induction
was 1.75-fold higher compared with the vehicle control group
when exogenous tRA and DEAB were added simultaneously to
Figure 2. mIMCD-3 cells as an in vitro model to examine target genes of endogenous tRA/RARs. mIMCD-3 cells expressed E-cadherin (E-
cad) (Ai) and aquaporin 2 (AQP2) (Aii) proteins. Left panels showed positive staining of specific antibodies, whereas right panels showed negative
controls of cells stained with the respective non-immune IgGs. Original magnification was 2006. Bi. Treating cells with 1 mM AGN193109 for 24 h
resulted in a decrease of RARE-luciferase activity to about 50% of that of the vehicle control group; the reduction was at least partially abolished with
simultaneous addition of exogenous tRA at 0.01–1 mM, in a dose-dependent manner. ** and ***: p,0.01 and p,0.001, respectively. Bii. Treating cells
with 25 mM DEAB for 72 h resulted in a suppression of RARE-luciferase activity to about 50% of that of vehicle control group; when exogenous tRA
was added during the last 24 h, the suppression of RARE-luciferase activity was reversed in a dose-dependent manner, saturated at 1 nM tRA. # and
##: p,0.05 and 0,0.01 vs vehicle control group, respectively; ** and ***: p,0.01 and p,0.001 vs DEAB-only group, respectively. Biii. When cells
were treated with exogenous tRA alone at 0.001–0.1 mM for 24 h, a slight trend of dose-dependent increase of RARE-luciferase activity was noted but
the difference was not statistically significant. Each dot represents mean value of triplicates or quadruplicates from a single biological experiment.
doi:10.1371/journal.pone.0045725.g002
Figure 3. Regulation of Bmp7 and Foxa1 by AGN193109 and 4-(diethylamino)benzaldehyde (DEAB) in pilot study. mRNA expression
of Bmp7 (Ai) and Foxa1 (Aii) was suppressed by AGN193109; the suppression was at least partially abolished in the presence of 0.2 mM tRA. Bi. Bmp7
mRNA was suppressed by DEAB; the suppression was reversed to a level slightly higher than basal level in the presence of 0.01 mM tRA. Bii.
Expression of Foxa1 mRNA was suppressed by DEAB; the suppression was partially abolished in the presence of 0.01 mM tRA. Each dot represents
mean value of three technical replicates from a single biological experiment. *, **, and ***: p,0.05, p,0.01, and p,0.001, respectively.
doi:10.1371/journal.pone.0045725.g003
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the cells. We interpreted this to mean that there was already
constitutive RAR activation by endogenous tRA in mIMCD-3
cells and that further activation was limited by low cellular uptake
of exogenous tRA, availability of RARs and/or transcriptional co-
regulators. On the other hand, when endogenous tRA synthesis
was abolished by DEAB, enhanced cellular uptake of exogenous
tRA and/or enhanced expression of RARs and co-factors might
have taken place, thus potentiating RARE-luciferase induction to
significantly higher than the basal level (Figure 2 Bii). Thus, for
cells with constitutively active endogenous tRA/RAR signaling
such as mIMCD-3 cells, instead of treating them directly with
exogenous tRA or RAR agonists to identify tRA/RAR target
genes, it would be more appropriate to determine genes
differentially regulated when endogenous tRA/RAR signaling
was inhibited (Figure 1).
By treating mIMCD-3 cells with AGN193109 and DEAB, with
and without exogenous tRA, we were able to catalogue a list of
candidate target genes specifically regulated by both endogenous
tRA and RARs. Note that when all shortlisted genes were
overlapped directly the intersected genes appeared to be the
minority (Figure 4A). However, only when the top 20 and top 10
most highly regulated genes were overlapped, did the intersected
genes become the majority (Figure 4B and 4C). This finding was
also reflected by the greater fold-changes observed for the
intersected genes compared with the non-intersected genes
(Figure 4A). Thus, the data suggest that RAR-independent tRA
signaling or tRA-independent RAR signaling might regulate
Figure 4. Candidate target genes short-listed from microarray experiments. A. A total of 403 and 439 unique genes were short-listed from
AGN193109 experiment and DEAB experiment, respectively. 133 genes were regulated by AGN193109 and DEAB; among them, 125 genes
(designated as group 1 genes), were regulated by AGN193109 and DEAB at similar directions, which the regulation was at least partially abolished in
the simultaneous presence of exogenous tRA. 270 genes were regulated only by AGN193109, of which regulation of 213 genes (designated as group
2 genes) was at least partially abolished in the simultaneous presence of exogenous tRA; 306 genes were regulated only by DEAB, of which regulation
of 266 genes (designated as group 3 genes) was at least partially abolished in the simultaneous presence of exogenous tRA. Note that the fold-
changes of intersected genes were higher than those of non-intersected genes. When ranked based on fold-changes, 80% of the top 20 most
regulated genes (B) and 90% of the top 10 most regulated genes were overlapped (C).
doi:10.1371/journal.pone.0045725.g004
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specific gene subsets, respectively. Nonetheless, genes most
dependent on retinoid signaling in mIMCD-3 cells were those
regulated by the canonical tRA/RAR signaling. We also found
that endogenous tRA/RAR signaling plays a primary role as
‘‘inducer’’ to support gene expression, rather than as ‘‘suppressor’’
to inhibit gene expression in mIMCD-3 cells, since genes
suppressed by AGN193109 and by DEAB greatly exceeded genes
induced by AGN193109 and by DEAB, in number of genes and
magnitude of regulation (Figure 5).
Among the 20 validated target genes of endogenous tRA/
RARs, including Foxa1 and Bmp7 identified in the pilot study
(Figure 6B), some were reported to be regulated by tRA and/or
RARs in previous reports, i.e., Dhrs3 (up-regulated) [29,30],
Sprr1a (down-regulated) [31,32], Cpm (down-regulated) [33],
Itga2 (up-regulated) [34], Ebf1 (up-regulated) [35], Lcn2 (up-
regulated) [36], Bmp7 (up-regulated) [24], and Foxa1 (up-
regulated) [25]. The remaining genes, i.e., Ppbp,
9930023K05Rik, Tns1, Klhdc7a, Sorcs2, 2310007B03Rik, Galns,
Npr3, Clca4, Upk3b, Slc37a1, and Hrsp12, represent novel target
genes of endogenous tRA/RARs, at least in mIMCD-3 cells.
Except for 9930023K05Rik, 2310007B03Rik, and Itga2, all
validated genes are expressed in native samples of UB/CD cells,
suggesting that they are of physiological relevance. We also noted
that half of these genes contain at least one DR5 RARE; among
them, almost all have at least one DR5 RARE within 10 kb from
transcription start sites and from gene ends, which are the regions
deemed most relevant for transcriptional activity modulation [4].
These genes might have been regulated via their DR5 RARE(s),
although other mechanisms, e.g., through other forms of RARE or
though RARE-independent mechanisms, might also be involved.
It is also worth noting that several well-established target genes of
tRA that have more than one functional DR5 RAREs, e.g., Rarb
and Cyp26a1 [25], were not shortlisted in the microarray
experiments. In fact, there was no statistically significant difference
in the retinoid binding proteins, metabolizing enzymes, and the
retinoid nuclear receptors, between the vehicle, inhibitors alone,
and inhibitors with exogenous tRA groups, as shown in the
microarray data. This could be explained by the cell type-
dependent activity of tRA, but treatment length might also have
an impact. Additional studies at earlier and later time points
should complement the existing profile of endogenous tRA/RAR
target genes in mIMCD-3 cells.
Among the top 50 biological processes that were significantly
enriched (Figure 6A), 42% was within the category of development
and morphogenesis, in agreement to the established role for tRA
as a morphogen. Apart from kidney development and other
previously reported tRA/RAR-dependent biological processes
[7,37], these genes are also involved in responses to external
stimuli, including oxygen levels, hormones, and chemicals,
consistent with the functions of CD cells to withstand the highly
variable oxygen levels, particularly in the medulla, as well as in
regulating water and solute transport.
Besides the classical functions of CD cells, emerging publica-
tions are suggesting novel functions for these cells, e.g., in
regulating inflammation, epithelial-mesenchymal transition and
fibrogenesis [38,39], as well as in defense against bacterial
infection [40], etc. Moreover, post-natal vitamin A deficiency
has been associated with renal anomalies, including increased
incidence of pyelonephritis, kidney inflammation and fibrosis,
polyuria and dysregulated urinary ion/solute content, urolithiasis,
Table 1. Top 20 most down-regulated genes.
Gene Symbol AGN193109 AGN193109+ tRA DEAB DEAB + tRA Entrez Genes
1. Ppbp 29.49 21.53 26.15 +1.85 57349
2. Dhrs3 28.59 23.78 25.02 +2.03 20148
3. Sprr1a 26.85 21.38 24.62 +2.53 20753
4. Cpm 25.15 21.69 22.30 +1.33 70574
5. 9930023K05Rik 24.36 21.59 22.35 +1.60 226245
6. Tns1 23.22 21.82 22.29 +1.27 21961
7. Itga2 23.22 21.16 22.56 +1.25 16398
8. Klhdc7a 23.10 21.87 22.11 +1.03 242721
9. Csn3 22.91 21.91 22.18 +1.18 12994
10. Sorcs2 22.66 21.46 22.05 +1.18 81840
11. Ebf1 22.66 21.43 22.43 +1.33 13591
12. Lcn2 22.48 21.28 21.78 +1.16 16819
13. 2310007B03Rik 22.31 21.58 21.42 1.00 71874
14. Galns 22.27 21.55 21.69 +1.07 50917
15. Npr3 22.21 21.03 21.99 +1.52 18162
16. Muc20 22.09 21.84 22.18 +1.08 224116
17. Clca4 22.07 +1.31 21.78 +1.94 229927
18. Upk3b 22.05 21.50 21.47 +1.07 100647
19. Slc37a1 22.00 21.33 21.53 +1.16 224674
20. Hrsp12 21.98 21.27 21.65 +1.06 15473
Shown here are mean fold-changes of gene expression compared to vehicle control from three experimental groups. Genes were sorted by fold-changes of AGN193109
group compared to vehicle group. Minus and plus numbers indicate folds of suppression and induction, respectively, in comparison to the vehicle control group, which
was normalized as 1.
doi:10.1371/journal.pone.0045725.t001
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Table 2. Top 20 most up-regulated genes.
Gene Symbol AGN193109 AGN193109+tRA DEAB DEAB+tRA Entrez Gene
1. Anxa8 +1.73 21.10 +1.43 21.54 11752
2. Ptgs2 +1.67 +1.48 +1.24 21.23 19225
3. Gsdma +1.61 21.01 +1.39 21.33 57911
4. Cpeb2 +1.57 +1.18 +1.24 21.15 231207
5. Ahnak2 +1.57 21.11 +1.42 21.42 100041194
6. Casp14 +1.56 21.11 +1.16 21.31 12365
7. Peg10 +1.52 +1.21 +1.35 21.16 170676
8. Ndrg1 +1.45 21.02 +1.32 21.24 17988
9. Rnf39 +1.45 +1.11 +1.18 21.19 386454
10. Pkp1 +1.40 +1.11 +1.25 21.20 18772
11. Alcam +1.39 1.00 +1.36 21.05 11658
12. Timp3 +1.39 21.03 +1.12 21.15 21859
13. Adora1 +1.38 +1.15 +1.27 21.08 11539
14. Car5b +1.36 +1.03 +1.13 21.28 56078
15. Atp6v0a4///D630045J12Rik +1.34 +1.11 +1.21 21.23 140494///330286
16. Egr1 +1.33 +1.24 +1.07 21.02 13653
17. Ly6c1///Ly6c2 +1.31 21.01 +1.14 21.20 17067///100041546
18. Cav1 +1.30 +1.02 +1.20 21.11 12389
19. Lama3 +1.28 21.02 +1.04 21.21 16774
20. Lmna +1.26 21.02 +1.17 21.17 16905
Shown here are mean fold-changes of gene expression compared to vehicle control from three experimental groups. Genes were sorted by fold-changes of AGN193109
group compared to vehicle group. Minus and plus numbers indicate folds of suppression and induction, respectively, in comparison to the vehicle control group, which
was normalized as 1.
doi:10.1371/journal.pone.0045725.t002
Figure 5. Candidate target genes of endogenous tRA/RARs: number of induced and suppressed genes. A total of 31 and 94 genes were
up-(red) and down-(green) regulated, respectively, by AGN193109 and by DEAB; regulation of these genes were at least partially abolished in the
presence of tRA. Of the 31 up-regulated genes, 24 were up-regulated by AGN193109 by less than 1.5-fold, 7 by more than 1.5-fold but less than 2-
fold, and none by 2-fold and more; none of the genes were up-regulated by DEAB by 1.5-fold and more. Of the 94 down-regulated genes, 38 were
down-regulated by AGN193109 by less than 1.5-fold, 37 by more than 1.5-fold but less than 2-fold, and 19 by 2-fold and more; 68 were down-
regulated by DEAB by less than 1.5-fold, 14 by more than 1.5-fold but less than 2-fold, and 12 by 2-fold and more.
doi:10.1371/journal.pone.0045725.g005
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and delayed tissue repair [7,41,42,43,44]. Thus, the roles for the
tRA/RAR target genes identified in this study in the aforemen-
tioned renal anomalies associated to post-natal vitamin A
deficiency deserve further studies.
Among the validated target genes, the top three genes that were
most dramatically regulated by tRA/RARs could have important
roles in mediating the biological processes and diseases mentioned
above. For instance, Ppbp could be regulating kidney development
[45], inflammation [46], and defense against bacterial infection
[47]; Sprr1a is another gene highly dependent on tRA/RAR
signaling inmediating tissue repair and regeneration [48] relevant to
kidney injury. It is important that while some validated genes, e.g.,
Dhrs3, Cpm, and Tns1, are expressed as cellular components, other
genes, e.g., Ppbp and Lcn2, are expressed as secreted proteins. This
supports the view that tRA/RARsnot only regulateCDcell function
in an autocrinemanner, but alsomodulate the function andhealth of
the kidney or the whole body in a non-autocrine manner. The
importance of tRA/RAR signaling in CD cells is also supported by
the regulation of Dhrs3 by AGN193109, DEAB and exogenous
tRA. Dhrs3 is involved in converting retinaldehyde back to vitamin
A to reduce tRA biosynthesis [30]. The pronounced regulation of
Dhrs3 might represent a self-regulatory mechanism of endogenous
tRA/RAR signaling in CD cells.
In summary, we have detected endogenous tRA/RAR activity
in mIMCD-3 cells, an in vitro cell model of the UB/CD cell
lineage. Using this model, a panel of genes regulated by both
endogenous tRA and RARs has been identified. Many of these
genes represent novel target genes of endogenous tRA/RARs. We
propose that endogenous tRA/RARs may play crucial roles in
kidney development and in maintaining normal function of CD
cells and the kidney, at least in part, by regulating these tRA/RAR
target genes. Given the complexity of retinoid signaling, which is
highly dependent on cell type and environment, further studies are
warranted to examine the regulation of these genes by tRA/RAR
signaling in vivo and to explore the potential role of these
endogenous tRA/RAR target genes in normal and abnormal
renal function.
Materials and Methods
Cell Culture
mIMCD-3 cells (LGC Standards, Middlesex, UK) were
routinely grown in DMEM-F12 (PAA Laboratories Ltd, Somerset,
UK) containing penicillin (100 IU/ml), streptomycin (100 mg/ml)
(PAA Laboratories Ltd) and amphotericin B (2.5 mg/ml) (Life
Technologies Ltd, Paisley, UK) herein referred as complete
Table 3. Validation of top 20 most down-regulated genes.
Gene Symbol AGN193109 AGN193109+tRA DEAB DEAB+tRA
1. Dhrs3 0.0160.0009*** 0.1460.0495‘‘‘ ** 0.0460.0052*** 2.8860.4050+++ **
2. Sprr1a 0.0560.0126*** 0.6060.0575‘‘‘ 0.1560.0195*** 4.1160.3857+++ ***
3. Ppbp 0.0760.0056*** 0.7360.0586‘‘‘ * 0.1460.0129*** 2.5660.1259+++ ***
4. 9930023K05Rik 0.1260.0072*** 0.6360.0326‘‘‘ ** 0.2860.0270*** 2.0960.1978+++ **
5. Cpm 0.1360.0217*** 0.4760.0053‘‘ * 0.3160.0240*** 1.4860.0393+++ **
6. Tns1 0.1460.0282** 0.3760.0587‘ * 0.3260.0272*** 1.5260.0506+++ *
7. Lcn2 0.1760.0090*** 0.7060.0604‘‘‘ * 0.2660.0057*** 1.5360.1460+++ *
8. Itga2 0.1960.0360** 0.9060.1579‘‘ 0.2760.0064*** 1.4460.1289+++ *
9. Npr3 0.2160.0356** 0.9360.1878‘‘ 0.3560.0374** 2.0960.1123+++ **
10. Klhdc7a 0.2160.0110** 0.4360.0740‘ * 0.3460.0249*** 1.2760.0792+++
11. Sorcs2 0.2560.0625** 0.6860.0667‘ 0.3460.0026*** 1.3460.1383+++
12. Clca4 0.2660.0526*** 1.7060.3294‘‘‘ 0.5360.0504** 2.6960.1611+++ **
13. 2310007B03Rik 0.2560.0269*** 0.5560.0100‘‘ ** 0.5960.0356** 1.1260.0751++
14. Muc20 0.3160.0248*** 0.4160.0573** 0.3660.0440** 1.2160.0852++
15. Upk3b 0.3560.0061*** 0.6560.0077‘‘‘ 0.5860.0125*** 1.1660.0190+++ **
16. Galns 0.3760.0007*** 0.6960.0407‘‘ 0.4460.0507** 1.1660.1101+++
17. Slc37a1 0.4060.0781** 0.7660.0342‘ 0.6160.0181*** 1.3060.0573+++ **
18. Ebf1 0.4460.0681** 0.8060.0313‘ 0.5460.0237** 1.5560.1321+++ **
19. Hrsp12 0.5260.0435** 0.8060.0561‘‘ 0.5760.0382** 1.1960.0826+++
20. Csn3 NA NA NA NA
Shown here are means of gene expression levels relative to vehicle control group 6 standard errors (SE); the vehicle control group was normalized as 1. Taking Dhrs3
expression as an example, 0.01 and 2.88 in the AGN193109 group and the DEAB+tRA group indicate 100-fold reduction and 2.88-fold induction relative to the vehicle
group, respectively.
*p,0.05 vs vehicle,
**p,0.01 vs vehicle,
***p,0.001 vs vehicle;
‘p,0.05 vs AGN193109,
‘‘p,0.01 vs AGN193109,
‘‘‘p,0.001 vs AGN193109;
+p,0.05 vs DEAB,
++p,0.01 vs DEAB,
+++p,0.001 vs DEAB; NA: Not amplified.
doi:10.1371/journal.pone.0045725.t003
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Figure 6. Gene ontologies, expression in native tissues, and presence of retinoic acid response element (RARE). A. Enrichment analysis
on the 125 candidate target genes showed that they are associated with many biological processes (green box) and diseases (red box), some of
which are highly relevant to renal physiology and pathology. Those marked with an asterisk were reported to be associated with tRA/RAR signaling.
The full list of gene ontologies for the 125 candidate target genes are in Table S4. B. (i) The 20 validated target genes of endogenous tRA/RARs were
reported to be involved in retinol metabolism (A), cell-cell, cell-substrate interaction (B), ureteric bud branching (C), immune/inflammatory processes
(D), oxidative stress (E), repair/regeneration (F), ion/solute/water transport and metabolism (G), and gene transcription/translation (H); functions of
9930023K05Rik, Klhdc7a, Sorcs2, and 2310007B03Rik are not yet known. Pink: GeneGO MetacoreTM, Yellow: DAVID [50], Green: GeneGO MetacoreTM
and DAVID, Blue: additional literature review [20,22,45,48,51,52,53]. The full list of gene ontologies for the 20 validate target genes are in Table S5. (ii)
Expression of the validated genes in native samples, available through Gene Expression Omnibus datasets (V: GSE6290, h: GSE7891), was reviewed.
E11.5 UB: embryonic day 11.5 ureteric bud cells from mice (three samples), E15.5 mCD: embryonic day 15.5 medullary collecting duct cells from mice
(three samples), rat IMCD: inner medullary collecting duct cells from rat (one sample from 6-week-old and two samples from 10-week-old). +: present,
2: absent, ud: undetermined; :ˆ present in 6-week-old sample but absent from 10-week-old samples. (iii) The number of direct-repeat 5 (DR5) RARE
that are present in the validated genes in whole mouse genome is summarized here, based on report from Lalevee et al. [4]. *: At least one of the DR5
RAREs is present within 10 kb from transcriptional start site and from gene end.
doi:10.1371/journal.pone.0045725.g006
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medium, supplemented with 5% fetal calf serum (FCS; Life
Technologies Ltd), at 37uC and 5% CO2.
Immunocytochemistry
Cells were seeded at 66105 cells/35 mm2 dish in 2 ml complete
medium, supplemented with 5% FBS. After an overnight culture
until confluent, cells were fixed with 5% ice-cold formalin for
15 min on ice, followed by washing with three changes of PBS,
5 min each wash. Cells were then permeabilized with 0.1% Triton
X-100 for 3 min and washed with three changes of PBS, 5 min
each wash. After fixation and permeabilization, cells were
incubated with 1% BSA for 2 h at room temperature to reduce
non-specific antibody binding, followed by 1 h incubation of
rabbit anti-AQP2 IgG (dilution 1:150, Millipore, Watford, UK), or
mouse anti-E-cad IgG2a (dilution 1:50, BD Biosciences, Oxford,
UK), at room temperature. Cells incubated with non-immune
rabbit IgG and non-immune mouse IgG2a (Insight Biotechnology
Ltd, Middlesex, UK) at the same concentrations served as negative
controls for anti-AQP2 IgG and for anti-E-cad IgG2a, respective-
ly. Cells were then washed with three changes of PBS, 5 min each
wash, and were incubated with goat anti-rabbit conjugated with
Alexa Fluor 488 (dilution 1:1000, Life Technologies Ltd) for
AQP2 detection or goat anti-mouse conjugated with Alexa Fluor
555 (dilution 1:1000, Life Technologies Ltd) for E-cad detection,
for 1 h at room temperature. At the end of secondary antibody
incubation, cells were washed with three changes of PBS, 5 min
each wash. One milliliter of fresh PBS was then pipetted onto the
cell monolayer and fluorescence microscopy was performed
immediately.
Microscopy
Phase-contrast and fluorescence microscopy was performed on
a Nikon Eclipse TE2000-S epifluorescence microscope equipped
with a standard RGB filter wheel (Nikon Instruments Europe
B.V., Amstelveen, The Netherlands). Images were captured with a
DXM1200F Nikon digital camera (Nikon UK Limited, Surrey,
UK), then processed and merged with Adobe Photoshop (Adobe
Systems Europe Ltd, Uxbridge, UK).
Reagents
tRA (Sigma-Aldrich Company Ltd, Dorset, UK) was reconsti-
tuted in 100% ethanol to 10 mM; DEAB [19] (Sigma-Aldrich
Company Ltd) was reconstituted in 100% dimethylsulphoxide
(DMSO) (Sigma-Aldrich Company Ltd) to 25 mM; AGN193109
[18], was reconstituted in 100% DMSO to 1 mM. All reagents
were first diluted with their respective diluents to 10006 more
concentrated than the working concentration, then diluted 10006
with culture medium to the working concentrations immediately
before treatment was commenced. Control groups were treated
with 0.1% ethanol and/or 0.1% DMSO.
Transient Transfection
LipofectamineTM LTX, PlusTM reagents and Opti-MEMH I
Reduced Serum Medium (Life Technologies Ltd) were used in
transient transfection of plasmid DNA according to the manufac-
turer’s instructions. pmaxGFP (Lonza Wokingham Ltd, Berkshire,
UK) was used to assess transfection efficiency; the transfection
efficiency was estimated to be around 70% (Figure S1). pGL3-
RARE-luciferase plasmid [49], was used to assess RAR-dependent
endogenous tRA activity. pCI-b-galactosidase plasmid (Promega,
Madison, USA) was used for normalization of RARE-luciferase
activity. Background signal was determined from wells treated
with transfection medium only without plasmid DNA. Ratio of
pGL3-RARE-luciferase: pCI-b galactosidase was 5:1 when co-
transfected into mIMCD-3 cells. Cells were lysed with Reporter
Lysis Buffer (Promega UK, Southampton, UK); luminescence
signal was detected with Luciferase Assay System and Beta-GloH
Assay System (Promega UK) and was expressed as relative light
unit (RLU). RLU of treatment group was normalized to vehicle
control group and expressed as fold-change.
RNA Extraction and Reverse Transcription-quantitative
Polymerase Chain Reaction (RT-qPCR)
Total RNA was extracted using RNeasyH Mini Kit and
QIAshredder spin column (Qiagen Ltd, West Sussex, UK)
following manufacturer’s protocol. Quantity and quality of total
RNA was determined with a NanoDropH ND-1000 machine
(Labtech International Ltd, East Sussex, UK); an absorbance ratio
of 260/280 and 260/230 for all total RNA samples were within
the range of 1.8–2.0. Reverse transcription was performed using
Oligo-d(T) primer and OmniscriptH Reverse Transcription Kit
(Qiagen Ltd) following manufacturer’s protocol. qPCR was
performed using TaqmanH universal master mix and TaqmanH
Gene Expression Assays (Life Technologies Ltd), as listed in
Table 4. Conditions for qPCR reactions were as follows: 50uC for
2 min, 95uC for 10 min, 40 cycles of 95uC for 15 s and 60uC for
1 min. Gene expression was computed using the 22DDCT
formula with glyceraldehyde 3-phosphate dehydrogenase (Gapdh)
as an internal control; gene expression of the vehicle control group
was normalized as 1. Expression of Gapdh was found to be stable
across all experimental groups (Figure S2).
Microarray
Samples were prepared using AmbionH WT kit (Life Technol-
ogies Ltd), Affymetrix fragmentation and labeling kit, and
Affymetrix wash, stain, and hybridization kit (Affymetrix UK
Ltd, High Wycombe, UK). Mouse Gene 1.0 ST array (Affymetrix
UK Ltd) was used for gene expression profiling. Agilent Nano
Chip and bioanalyser (Agilent Technologies UK Ltd, Edinburgh,
UK) were used to assess the quality of total RNA; there was no
evident of RNA degradation, as shown in Figure S3. Nucleotide
size of sense-cDNA was also examined before and after
fragmentation. An AffymetrixH Gene Control Console software
was used for data normalization using the Robust Multichip
Average method. Candidate target genes were short-listed using
an Qlucore Omics Explorer software with multiple comparison
analysis, by using Foxa1 as the cut-off threshold of statistical
significance (variance = 0.098, q = 0.65 for AGN193109 experi-
ment; variance = 0.053, q = 0.30 for DEAB experiment). The
RNA samples used for microarray experiments were subsequently
used in the validation experiments.
Gene Ontology Analysis
Gene ontology analysis was performed using Database for
Annotation, Visualization and Integrated Discovery (DAVID)
(http://david.abcc.ncifcrf.gov/) [50] and GeneGO MetacoreTM
(GeneGO Inc., St. Joseph, Michigan); additional literature reviews
were performed to complement gene ontology analysis.
Experimental Protocols
For reporter assays involving AGN193109 and tRA, mIMCD-3
cells were seeded into a 24-well plate at 46104 cells/well in 500 ml
of DMEM-F12 medium without antibiotics and anti-mycotic,
supplemented with 5% FCS. After culturing for 16–24 h to about
70% confluence, cells were co-transfected with pGL3-RARE-
luciferase and pCI-b-galactosidase plasmids, and cultured for
RA/RAR Target Genes in Collecting Duct Cells
PLOS ONE | www.plosone.org 11 September 2012 | Volume 7 | Issue 9 | e45725
another 5 h. Medium was then changed to fresh complete
medium supplemented with 1% FCS. After an overnight
incubation, medium was changed to fresh complete medium
supplemented with 1% FCS containing 1 mM AGN193109, with
and without 0.01 mM, 0.1 mM, or 1 mM tRA, and cultured for
24 h. For reporter assays involving tRA alone, the protocol was
similar as above, except that cells were treated with 0.001 mM,
0.01 mM, or 0.1 mM tRA for 24 h.
For reporter assays involving DEAB and tRA, mIMCD-3 cells
were seeded into a 24-well plate at 26104 cells/well in 500 ml of
DMEM-F12 medium without antibiotics and anti-mycotic,
supplemented with 5% FCS. Cells were cultured for 16–24 h to
about 40–50% confluence, and medium was changed to fresh
DMEM-F12 without antibiotics and anti-mycotic, supplemented
with 1% FCS, and contained 25 mM DEAB or vehicle. Cells were
then cultured for 16–24 h until about 70% confluence, after which
medium changing was repeated as described above and cells were
co-transfected with pGL3-RARE-luciferase and pCI-b-galactosi-
dase plasmids. After an overnight incubation, medium was again
changed to fresh DMEM-F12 without antibiotics and anti-
mycotic, supplemented with 1% FCS, and contained 25 mM
DEAB, with and without 0.0001 mM, 0.001 mM, 0.01 mM, or
0.1 mM tRA. Cells were then cultured for 24 h.
For RT-qPCR and microarray experiments, cells were seeded
at 1.2–26105 cells/35 mm2 dish in 2 ml complete medium,
supplemented with 5% FCS. After an overnight culture, medium
was changed to fresh complete medium supplemented with 1%
FCS. After an overnight culture, medium was again changed to
fresh complete medium supplemented with 1% FCS, containing
1 mM AGN193109 with and without 0.2 mM tRA, or 25 mM
DEAB with and without 0.01 mM tRA, and cultured for 24 h.
Control groups were treated with vehicle in all aforementioned
protocols. For reporter assays, three independent experiments,
with triplicate or quadruplicate wells for each group, were
performed. For microarray and RT-qPCR experiments, three
independent experiments were performed.
Statistical Test for Reporter Assay and qPCR
For reporter assays and RT-qPCR experiments, One-way
Analysis of Variance (ANOVA) statistical analysis with Tukey
post-test was performed on log-transformed fold-change values
using GraphPad Prism, Version 4.0. p,0.05 was considered as
statistically significant.
Supporting Information
Figure S1 Transfection efficiency assessed from green
fluorescent protein (GFP) expression. Around 60% to 70%
of the total mIMCD-3 cells transfected with pmaxGFP plasmid
expressed GFP (green). No GFP expression was observed in cells
where only transfection reagents were added. Original magnifica-
tion was 1006.
(TIFF)
Figure S2 Amplification plot of glyceraldehyde 3-phos-
phate dehydrogenase (Gapdh). Expression of Gapdh did not
vary much between the vehicle control group and 24 h treatment
of AGN193109 with and without tRA (A), and of DEAB with and
without tRA (B), evident by a tight overlapping amplification plots
across all the samples. Representative amplification plots derived
from technical triplicates of a single biological experiment are
shown here.
(TIFF)
Figure S3 RNA integrity of samples for microarray
experiments. Integrity of RNA samples from AGN193109
experiment (A) and DEAB experiment (B) was examined with
bioanalyser. The two sharp major peaks correspond to 18s and 28s
ribosomal RNA, respectively. The high RNA Integrity Number
(RIN) values, within the range of 9.70–10.00, suggest a good
quality of RNA samples with minimum degradation of RNA.
There is no evidence of genomic DNA contamination in the RNA
samples, given the presence of thin and sharp 18s and 28s RNA
peaks, as well as absence of additional peaks other than the
expected ribosomal RNA peaks.
(TIFF)
Table S1 133 intersected genes.
(XLS)
Table S2 270 genes regulated by AGN193109.
(XLS)
Table S3 306 genes regulated by DEAB.
(XLS)
Table S4 Gene ontology for 125 candidate target genes.
(XLS)
Table S5 Gene ontology for validated genes.
(XLS)
Table 4. Assay ID and amplicon length of TaqmanH Gene
Expression Assays used.
Gene Assay ID Amplicon length
1. Bmp7 Mm00432101_m1 82
2. Clca4 Mm00519742_m1 68
3. Cpm Mm01250796_m1 63
4. Csn3 Mm02581554_m1 99
5. Dhrs3 Mm00488080_m1 84
6. Ebf1 Mm00432948_m1 59
7. Foxa1 Mm00484713 _m1 68
8. Galns Mm00489576_m1 80
9. Gapdh Mm99999915 _m1 107
10. Hrsp12 Mm00476177_m1 73
11. Itga2 Mm00434371_m1 63
12. Klhdc7a Mm00557861_s1 117
13. Lcn2 Mm01324470_m1 84
14. Muc20 Mm00524818_m1 65
15. Npr3 Mm00435329_m1 63
16. Pax2 Mm01217939_ m1 55
17. Ppbp Mm00470163_m1 62
18. Slc37a1 Mm00461949_m1 78
19. Sorcs2 Mm00473050_m1 64
20. Sprr1a Mm01962902_s1 94
21. Tns1 Mm00452886_m1 91
22. Upk3b Mm00558406_m1 89
23. Wnt7b Mm00437357_ m1 88
24. 9930023K05Rik Mm00554061_m1 110
25. 2310007B03Rik Mm00549644_m1 73
doi:10.1371/journal.pone.0045725.t004
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